Raphael Pak

2.8k total citations · 1 hit paper
22 papers, 2.1k citations indexed

About

Raphael Pak is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Raphael Pak has authored 22 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Raphael Pak's work include Atrial Fibrillation Management and Outcomes (5 papers), Hormonal and reproductive studies (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Raphael Pak is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Hormonal and reproductive studies (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Raphael Pak collaborates with scholars based in Canada, United States and United Kingdom. Raphael Pak's co-authors include Alexander Gallus, Gary E. Raskob, Giancarlo Agnelli, Jeffrey I. Weitz, Alexander T. Cohen, Madelyn Curto, Margot Johnson, Harry R. Büller, Urszula Masiukiewicz and John R. Thompson and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of the American College of Cardiology.

In The Last Decade

Raphael Pak

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

2013 1.7k citations Giancarlo Agnelli, Harry R. Büller et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raphael Pak Canada	10	1.7k	1.6k	424	231	226	22	2.1k
Peter Nicol Sweden	12	1.4k 0.8×	1.5k 1.0×	586 1.4×	617 2.7×	205 0.9×	17	2.7k
M Pini Italy	17	1.8k 1.1×	1.3k 0.8×	634 1.5×	426 1.8×	377 1.7×	53	2.3k
Ákos F. Pap Germany	17	1.8k 1.1×	1.7k 1.1×	513 1.2×	350 1.5×	210 0.9×	37	2.2k
Margot Johnson United States	7	2.4k 1.4×	2.2k 1.4×	490 1.2×	400 1.7×	236 1.0×	9	2.7k
Luc Sagnard France	10	1.1k 0.7×	1.3k 0.8×	746 1.8×	250 1.1×	184 0.8×	13	1.8k
Marco Paolo Donadini Italy	21	989 0.6×	659 0.4×	370 0.9×	288 1.2×	224 1.0×	69	1.4k
Harry R. Büller Netherlands	18	1.6k 1.0×	1.1k 0.7×	582 1.4×	552 2.4×	317 1.4×	28	2.3k
Mauro Silingardi Italy	20	1.3k 0.8×	1.1k 0.7×	376 0.9×	399 1.7×	161 0.7×	50	2.1k
Linda Harrison Canada	7	954 0.6×	900 0.6×	402 0.9×	241 1.0×	100 0.4×	8	1.2k
Turnly Wong Canada	6	964 0.6×	851 0.5×	351 0.8×	265 1.1×	277 1.2×	6	1.2k

Countries citing papers authored by Raphael Pak

Since Specialization

Citations

This map shows the geographic impact of Raphael Pak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Pak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Pak more than expected).

Fields of papers citing papers by Raphael Pak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Pak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Pak. The network helps show where Raphael Pak may publish in the future.

Co-authorship network of co-authors of Raphael Pak

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Pak. A scholar is included among the top collaborators of Raphael Pak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Pak. Raphael Pak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agnelli, Giancarlo, H.R. Büller, Alexander Cohen, et al.. (2015). Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. Journal of Thrombosis and Haemostasis. 13(12). 2187–2191. 150 indexed citations

Cohen, Alexander T., Alexander Gallus, Giancarlo Agnelli, et al.. (2014). Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data. Blood. 124(21). 1543–1543. 5 indexed citations

Agnelli, Giancarlo, H.R. Büller, A. Cohen, et al.. (2014). APIXABAN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS: DATA FROM THE AMPLIFY TRIAL. Canadian Journal of Cardiology. 30(10). S278–S278. 16 indexed citations

Agnelli, Giancarlo, Harry R. Büller, Alexander T. Cohen, et al.. (2013). Oral Apixaban for the Treatment of Acute Venous Thromboembolism. New England Journal of Medicine. 369(9). 799–808. 1657 indexed citations breakdown →

Cohen, Alexander T., Rebecca A. Boyd, Jaap W. Mandema, Lorenzo A. DiCarlo, & Raphael Pak. (2013). An adaptive‐design dose‐ranging study of PD 0348292, an oral factor Xa inhibitor, for thromboprophylaxis after total knee replacement surgery. Journal of Thrombosis and Haemostasis. 11(8). 1503–1510. 14 indexed citations

Mohler, Emile R., Sanjay Rajagopalan, Jeffrey W. Olin, et al.. (2003). Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial. Vascular Medicine. 8(1). 9–13. 48 indexed citations

Rajagopalan, Sanjay, Jeffrey Trachtenberg, Jeffrey W. Olin, et al.. (2002). Long-term safety and efficacy of intramuscular administration of Cl-1023 (AdGVVEGF121.10) in patients with intermittent claudication. Journal of the American College of Cardiology. 39. 205–205. 1 indexed citations

Rajagopalan, Sanjay, Jeffrey Trachtenberg, Emile R. Mohler, et al.. (2002). Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication. The American Journal of Cardiology. 90(5). 512–516. 40 indexed citations

Solomkin, Joseph S., Samuel E. Wilson, N. V. Christou, et al.. (2001). Results of a Clinical Trial of Clinafloxacin Versus Imipenem/Cilastatin for Intraabdominal Infections. Annals of Surgery. 233(1). 79–87. 42 indexed citations

10.

Bellward, Gail D., et al.. (1992). Imprinting of hepatic microsomal cytochrome P-450 enzyme activities and cytochrome P-450IIC11 by peripubertal administration of testosterone in female rats.. Molecular Pharmacology. 41(5). 981–988. 11 indexed citations

11.

Pak, Raphael. (1988). Effects of a testicotoxic dose of cadmium on the liver and drug metabolism in the rat. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 89(2). 305–309. 4 indexed citations

12.

Sunahara, Geoffrey I., Raphael Pak, & Gail D. Bellward. (1987). Effect of flutamide on hepatic cytosolic methyltrienolone (R1881) binding kinetics and testosterone responsive hepatic drug and steroid metabolism in the adult male rat. Biochemical Pharmacology. 36(21). 3571–3577. 5 indexed citations

13.

Pak, Raphael, Karl Wah Keung Tsim, & Christopher H.K. Cheng. (1985). The role of neonatal and pubertal gonadal hormones in regulating the sex dependence of the hepatic microsomal testosterone 5-reductase activity in the rat. Journal of Endocrinology. 106(1). 71–79. 2 indexed citations

14.

Pak, Raphael, Karl Wah Keung Tsim, & Christopher H.K. Cheng. (1984). Pubertal Gonadal Hormones in Modulating the Testosterone Dependency of Hepatic Aryl Hydrocarbon Hydroxylase in Female Rats. Pharmacology. 29(3). 121–127. 6 indexed citations

15.

Cheng, Christopher H.K., et al.. (1984). Rat hepatic prolactin receptor: pubertal exposure to sex steroids alters responsivity to testosterone. International journal of peptide & protein research. 23(5). 521–527. 9 indexed citations

16.

Pak, Raphael, et al.. (1983). Differential effects of diabetes on microsomal metabolism of various substrates. Biochemical Pharmacology. 32(2). 327–335. 45 indexed citations

17.

Pak, Raphael & D. J. Ecobichon. (1982). Disposition of maternally-administered methadone and its effects on hepatic drugmetabolizing functions in perinatal guinea pigs. Biochemical Pharmacology. 31(18). 2941–2947. 4 indexed citations

18.

Pak, Raphael & D. J. Ecobichon. (1981). The effect of pregnancy and lactation on the elimination of methadone in guinea pigs.. Drug Metabolism and Disposition. 9(2). 170–171. 8 indexed citations

19.

Pak, Raphael & D. J. Ecobichon. (1981). Methadone Hydrochloride: Acute Administration, Disposition and Effects on Hepatic Function in Guinea Pigs. Drug and Chemical Toxicology. 4(2). 173–184. 2 indexed citations

20.

Pak, Raphael & D. J. Ecobichon. (1978). Methadone hydrochloride: effects of acute administration on disposition and hepatic function in guinea pigs. Canadian Journal of Physiology and Pharmacology. 56(4). 610–616. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact